OSSSC Nursing Disease Guide

Communicable · High priority

Japanese encephalitis

Core disease facts with the linked government programme, prevention and treatment or cure reality.

TypeViral disease — caused by Japanese encephalitis virus.

Image-based identification

Adult Culex tritaeniorhynchus mosquito
What to identifyAssociate Japanese encephalitis with the Culex tritaeniorhynchus mosquito—not Aedes or Anopheles.Image credit: Michael Wunderli — CC BY 2.0

Government programmes, schemes and services

  • Programme: National Vector Borne Disease Control Programme: Works to reduce Japanese encephalitis illness and deaths through surveillance, vector control, training and case-management support.
  • Programme: Universal Immunisation Programme: Provides Japanese encephalitis vaccine in selected endemic districts according to the national schedule and campaign policy.
  • Surveillance: Acute Encephalitis Syndrome/Japanese encephalitis surveillance: Investigates encephalitis cases, obtains laboratory confirmation and supports early outbreak response.

Prevention

  • Prevent: Japanese encephalitis vaccination in selected districts, mosquito control, bite protection, appropriate pig-rearing measures

Treatment and cure reality

  • Treat: No specific antiviral cure. Supportive intensive care, seizure control, airway and complication management.

Must remember

  • Vector: Mainly Culex vishnui group mosquitoes.
  • Amplifying host: Pigs; ardeid water birds are maintenance hosts.
  • Human role: Humans are usually dead-end hosts; mosquitoes generally do not acquire sufficient virus from a patient to continue transmission.
  • Severe features: Fever, headache, altered sensorium, seizures, focal neurological deficits, and coma.
  • Treatment: Supportive; no specific antiviral treatment routinely cures Japanese encephalitis.
  • Prevention: Vector control, personal protection, separation of pigsties from homes where feasible, and vaccination.
  • Schedule: In selected endemic districts, Japanese encephalitis vaccine is given at 9–12 months and 16–24 months.